117 related articles for article (PubMed ID: 3636196)
1. Induction of neutrophil enzyme release by rheumatoid factors: evidence for differences based on molecular characteristics.
Blackburn WD; Koopman WJ; Schrohenloher RE; Heck LW
Clin Immunol Immunopathol; 1986 Aug; 40(2):347-55. PubMed ID: 3636196
[TBL] [Abstract][Full Text] [Related]
2. Complement-activating properties of IgM rheumatoid factors reacting with IgG subclasses.
Sato Y; Watanabe H; Kogure A; Miyata M; Watanabe K; Nishimaki T; Kasukawa R; Fujita T
Clin Rheumatol; 1995 Jul; 14(4):425-8. PubMed ID: 7586979
[TBL] [Abstract][Full Text] [Related]
3. IgA Complexes in Plasma and Synovial Fluid of Patients with Rheumatoid Arthritis Induce Neutrophil Extracellular Traps via FcαRI.
Aleyd E; Al M; Tuk CW; van der Laken CJ; van Egmond M
J Immunol; 2016 Dec; 197(12):4552-4559. PubMed ID: 27913645
[TBL] [Abstract][Full Text] [Related]
4. IgG Subclass Specificity Discriminates Restricted IgM Rheumatoid Factor Responses From More Mature Anti-Citrullinated Protein Antibody-Associated or Isotype-Switched IgA Responses.
Falkenburg WJ; van Schaardenburg D; Ooijevaar-de Heer P; Wolbink G; Rispens T
Arthritis Rheumatol; 2015 Dec; 67(12):3124-34. PubMed ID: 26246004
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of IgM-, IgA- and IgG-rheumatoid factors in seronegative polyarticular disease compared to pauciarticular disease in juvenile chronic arthritis as measured by ELISA.
Varbanova BB; Baleva M; Nikolov K; Mihailova D
Adv Exp Med Biol; 1999; 455():61-8. PubMed ID: 10599324
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil lysosomal dysfunctions in mutant C57 Bl/6J mice: interstrain variations in content of lysosomal elastase, cathepsin G and their inhibitors.
Gardi C; Cavarra E; Calzoni P; Marcolongo P; de Santi M; Martorana PA; Lungarella G
Biochem J; 1994 Apr; 299 ( Pt 1)(Pt 1):237-45. PubMed ID: 8166647
[TBL] [Abstract][Full Text] [Related]
7. At least three human neutrophil lysosomal proteases are capable of degrading joint connective tissues.
Janoff A
Ann N Y Acad Sci; 1975 Jun; 256():402-8. PubMed ID: 240305
[No Abstract] [Full Text] [Related]
8. Human mononuclear cells and neutral proteinases. III. Neutral proteinases and rheumatoid arthritis: monocytes as a source of cathepsin G and proteinase potentiation of IgM rheumatoid factor elaboration.
Panush RS
Inflammation; 1989 Jun; 13(3):359-66. PubMed ID: 2753524
[TBL] [Abstract][Full Text] [Related]
9. Comparative specificities of serum and synovial cell 19S IgM rheumatoid factors in rheumatoid arthritis.
Robbins DL; Wistar R
J Rheumatol; 1985 Jun; 12(3):437-43. PubMed ID: 3900391
[TBL] [Abstract][Full Text] [Related]
10. A quantitative assay for IgA rheumatoid factor.
Koopman WJ; Schrohenloher RE; Solomon A
J Immunol Methods; 1982; 50(1):89-98. PubMed ID: 7086151
[TBL] [Abstract][Full Text] [Related]
11. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
[TBL] [Abstract][Full Text] [Related]
12. Molecular forms of IgA rheumatoid factor in serum and synovial fluid of patients with rheumatoid arthritis.
Schrohenloher RE; Koopman WJ; Alarcón GS
Arthritis Rheum; 1986 Oct; 29(10):1194-202. PubMed ID: 3768056
[TBL] [Abstract][Full Text] [Related]
13. Effects of gold therapy on the synthesis and quantity of serum and synovial fluid IgM, IgG, and IgA rheumatoid factors in rheumatoid arthritis patients.
Hanly JG; Hassan J; Whelan A; Feighery C; Bresnihan B
Arthritis Rheum; 1986 Apr; 29(4):480-7. PubMed ID: 3707625
[TBL] [Abstract][Full Text] [Related]
14. [Measurement and comparison of the rheumatoid factors class IgG, IgM and IgA in chronic juvenile rheumatoid arthritis].
Alvarez García J; Blanco Quirós A; Solís Sánchez P; Tellería Orriols JJ; Lapeña López de Armentiá S
An Esp Pediatr; 1989 Dec; 31(6):554-8. PubMed ID: 2698069
[TBL] [Abstract][Full Text] [Related]
15. Lysosomal enzymes in inflammatory synovial effusions.
Hadler NM; Spitznagel JK; Quinet RJ
J Immunol; 1979 Aug; 123(2):572-7. PubMed ID: 222841
[TBL] [Abstract][Full Text] [Related]
16. Isolation and analysis of complement activating aggregates from synovial fluid of patients with rheumatoid arthritis using monoclonal anti-C3d antibodies.
Bedwell AE; Elson CJ; Carter SD; Dieppe PA; Hutton CW; Czudek R
Ann Rheum Dis; 1987 Jan; 46(1):55-64. PubMed ID: 3492971
[TBL] [Abstract][Full Text] [Related]
17. Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 ('gelatinase') by human neutrophil elastase and cathepsin G.
Okada Y; Nakanishi I
FEBS Lett; 1989 Jun; 249(2):353-6. PubMed ID: 2544455
[TBL] [Abstract][Full Text] [Related]
18. Degradation in vivo of articular cartilage in rheumatoid arthritis and juvenile chronic arthritis by cathepsin G and elastase from polymorphonuclear leukocytes.
Velvart M; Fehr K
Rheumatol Int; 1987; 7(5):195-202. PubMed ID: 3423618
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin S and cathepsin L in serum and synovial fluid in rheumatoid arthritis with and without autoantibodies.
Weitoft T; Larsson A; Manivel VA; Lysholm J; Knight A; Rönnelid J
Rheumatology (Oxford); 2015 Oct; 54(10):1923-8. PubMed ID: 26060322
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of neutrophil elastase by the alpha1-proteinase inhibitor-immunoglobulin A complex.
Adam C; Bieth JG
FEBS Lett; 1996 May; 385(3):201-4. PubMed ID: 8647251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
